Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Healthcare Biotechnology
Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > -----HAVE VAXIL MISSED THE BOAT ?---
View:
Post by threefiftynine on Jun 27, 2020 9:19am

-----HAVE VAXIL MISSED THE BOAT ?---

Way too busy trying to raise a few million and further diluting the company whilst th govt throws money around.If they had the goods "BIG PHARMA"companies would be all over this company with funds. No news for months on clinical testing is a red flag --The CEO is failng badly and his bandwagon moving away from cancer testing to covid 19 has failed imo ---- -------------------just one example -Read This :--
Comment by threefiftynine on Jun 27, 2020 9:20am
Entos Pharmaceuticals, led by University of Alberta researcher Dr. John Lewis, has selected two promising vaccine prototypes to start testing in people. We have two really excellent candidates that produce a very strong neutralizing antibody immune response [in animals], Lewis told Global News. The Government of Canada has granted Lewis $4.2 million to take the project to the next step, part of ...more  
Vaxil Bio Ltd